Stockscreener 앱 받기
10.60
9.28%
0.90
시간 외 거래:
10.60
전일 마감가:
$9.70
열려 있는:
$9.65
하루 거래량:
1.02M
Relative Volume:
1.48
시가총액:
$629.93M
수익:
$133.62M
순이익/손실:
$-177.37M
주가수익비율:
-3.6678
EPS:
-2.89
순현금흐름:
$23.50M
1주 성능:
+18.57%
1개월 성능:
-19.70%
6개월 성능:
-49.72%
1년 성능:
-42.33%
1일 변동 폭
$9.46
$10.98
1주일 범위
$8.82
$10.98
52주 변동 폭
$7.16
$27.24
Xencor Inc Stock (XNCR) Company Profile
명칭
Xencor Inc
전화
626-305-5900
주소
465 N. HALSTEAD ST., PASADENA, CA
XNCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
10.60 | 629.93M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 개시 | Wells Fargo | Overweight |
| 2024-12-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | 재확인 | BTIG Research | Buy |
| 2024-02-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | 개시 | BofA Securities | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-10-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-02-11 | 개시 | BMO Capital Markets | Outperform |
| 2022-01-21 | 개시 | SMBC Nikko | Outperform |
| 2021-12-15 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-02-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | 개시 | Barclays | Underweight |
| 2020-02-25 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-01-30 | 개시 | RBC Capital Mkts | Outperform |
| 2019-11-20 | 재개 | Guggenheim | Neutral |
| 2019-08-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | 개시 | Mizuho | Buy |
| 2019-04-12 | 개시 | Guggenheim | Buy |
| 2019-03-27 | 개시 | Berenberg | Buy |
| 2019-03-15 | 개시 | Raymond James | Outperform |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-03-28 | 재개 | Leerink Partners | Outperform |
| 2017-03-02 | 개시 | Instinet | Neutral |
| 2017-03-02 | 재확인 | Wedbush | Outperform |
| 2016-10-04 | 개시 | Piper Jaffray | Overweight |
| 2015-12-22 | 개시 | Canaccord Genuity | Buy |
| 2015-08-05 | 재확인 | MLV & Co | Buy |
| 2015-02-12 | 재확인 | Oppenheimer | Outperform |
| 2015-01-28 | 재확인 | MLV & Co | Buy |
| 2014-07-11 | 개시 | Oppenheimer | Outperform |
모두보기
Xencor Inc 주식(XNCR)의 최신 뉴스
Xencor Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
William Blair starts Xencor stock with Outperform rating By Investing.com - Investing.com South Africa
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Buy” by Analysts - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Acquires 179,526 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Wellington Management Group LLP Purchases Shares of 27,491 Xencor, Inc. (NASDAQ:XNCR) - The AM Reporter
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor CFO Cornelissen sells $30,232 in company stock By Investing.com - Investing.com India
Xencor CFO sells $30,232 in company stock - Investing.com
Xencor CFO Cornelissen sells $30,232 in company stock - Investing.com
Xencor CFO sells $30,232 in company stock By Investing.com - Investing.com South Africa
Xencor (NASDAQ:XNCR) Sets New 1-Year LowHere's Why - MarketBeat
Xencor, Inc.: No Major Near Term Catalysts (NASDAQ:XNCR) - Seeking Alpha
Xencor (XNCR) Upgraded to Buy: Here's Why - Yahoo Finance
Federal Circuit’s Xencor Decision: Considerations for Jepson Claims and Implications for 35 U.S.C. § 101 Analysis - NatLawReview.com
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com Canada
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India
American Century Companies Inc. Has $2.63 Million Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Vanguard Group Inc. - Defense World
KLP Kapitalforvaltning AS Invests $280,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Prudential Financial Inc. - Defense World
Corebridge Financial Inc. Has $826,000 Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor stock hits 52-week low at $9.34 amid market challenges - Investing.com
Xencor stock hits 52-week low at $9.34 amid market challenges By Investing.com - Investing.com South Africa
End of the Road for Jepson Format Claims in the Life Sciences? - JD Supra
Teacher Retirement System of Texas Has $428,000 Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely - simplywall.st
Raymond James Financial Inc. Acquires New Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Swiss National Bank - Defense World
Even Jepson Preambles Require Written Description Support - The National Law Review
PNC Financial Services Group Inc. Raises Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor stock touches 52-week low at $12.53 amid market challenges By Investing.com - Investing.com South Africa
Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com India
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World
When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Armenian Reporter
Charles Schwab Investment Management Inc. Purchases 3,652 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Amundi Acquires 24,494 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Bank of New York Mellon Corp Purchases 18,586 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Federal Circuit Rules Jepson Claims Need Full Written Description: Another Nail in the Coffin - Patently-O
Xencor (NASDAQ:XNCR) Stock Rating Lowered by StockNews.com - Defense World
Fed. Circ. Dings Antibody Patent App For Lacking Description - Law360
Xencor Appoints Todd Simpson To Board Of Directors -March 13, 2025 at 05:31 pm EDT - Marketscreener.com
Xencor Appoints Todd Simpson to Board of Directors - sharewise
Xencor Strengthens Board with Veteran Biotech CFO Behind Seagen's Multi-Billion Success - StockTitan
Xencor’s SVP sells $78,047 in stock By Investing.com - Investing.com India
Xencor’s EVP Nancy Valente sells $34,876 in stock By Investing.com - Investing.com Canada
Antibody Humanization Market Critical Analysis with Expert Opinion: Genentech, Adimab, Xencor - openPR
Xencor Inc (XNCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
4.32%
자본화:
|
볼륨(24시간):